Sterling Johnson, PhD

Dr. Johnson is a clinical neuropsychologist with research interests in early identification of Alzheimer's disease and related disorders. He leads the Wisconsin Registry for Alzheimer’s Prevention (WRAP), a longitudinal cohort study of 1500+ people at varying levels of risk for sporadic Alzheimer's disease. He is the associate director and Biomarker Core leader in the Wisconsin ADRC, as well as the associate director of the Wisconsin Alzheimer's Institute. In 2022, he was awarded the Vilas Distinguished Achievement Professorship, recognize UW–Madison faculty members whose distinguished scholarship has advanced the confines of knowledge, and whose excellence also includes teaching or service.

Johnson is also the lead principal investigator for the ADRC Consortium for Clarity in ADRD Research Through Imaging (CLARiTI). ADRC’s nationwide collaborate in CLARiTI for the purpose of elucidating the multiple intersecting etiologies that cause cognitive impairment and that may be present in any given patient. CLARiTI launched in 2023 and will establish standardized brain imaging and blood plasma test protocols to analyze levels and types of amyloid and tau, which are hallmark biomarkers of Alzheimer’s disease, together with assays of other proteinopathies.

Johnson is also an affiliate of the Institute on Aging and Department of Psychology at the University of Wisconsin–Madison.